Research Paper Volume 15, Issue 20 pp 10996—11011
BTN2A2, a new biomarker and therapeutic target for glioma
Figure 5. Enrichment analysis of BTN2A2 in glioma. (A–C) The GO enrichment analysis was performed on BTN2A2 using TCGA. (D) The KEGG pathway analysis of BTN2A2 using the TCGA database.